Antithrombotic Effects GLP-1 agonists reduce cardiovascular events through several mechanisms previously summarized to include improved glycemic control, weight loss, lowering blood pressure, lipid lowering, reduced atherogenesis, attenuated vascular inflammation, improved endothelial cell function, vasodilation, and direct cardiovascular protective effects [88, 89]
Structure Therapeutics is among the most advanced challengers, with its oral GLP-1 receptor agonist aleniglipron generating Phase 2 data that has drawn significant industry attention
Qualified healthcare providers must evaluate each patient's medical history, concurrent medications, and metabolic markers before recommending a specific GLP-1 supplement
Isothiocyanates have been found to inhibit HDAC expression and/or activity in cultured cancer cells (38-43)
Valproate Valproate ( valproic acid , VPA , sodium valproate , and valproate semisodium forms) are medications primarily used to treat epilepsy and as a mood stabilizer in the treatment of bipolar disorder
Pycnogenol showed effects to stop further progression of retinopathy and ameliorate the eyesight of diabetics by stabilizing and sealing leaky capillaries of the retina, stopping further outflow of blood ( In an RDP study, Pycnogenol was shown to reduce capillary leaking in the eyes ( supplementation for two months, the ophthalmoscopy score significantly improved by 9% in the left eyes and by 17% in the right eyes compared to baseline, whereas there was no change observed in the placebo group